Jounce Therapeutics
JNCE
#9239
Rank
โ‚ฌ86.31 M
Marketcap
1,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
-51.07%
Change (1 year)

Revenue for Jounce Therapeutics (JNCE)

Revenue in 2022 (TTM): โ‚ฌ76.44 Million

According to Jounce Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ69.67 Million. In 2021 the company made a revenue of โ‚ฌ23.75 Million a decrease over the revenue in the year 2020 that were of โ‚ฌ50.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jounce Therapeutics from 2016 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ76.44 M221.75%
2021 โ‚ฌ23.75 M-53.12%
2020 โ‚ฌ50.68 M-61.6%
2019 โ‚ฌ0.13 B131.61%
2018 โ‚ฌ56.99 M-4.55%
2017 โ‚ฌ59.71 M68.85%
2016 โ‚ฌ35.36 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA